Way2Grow Biopharma Company Announces Plans to Seek Health Canada Approval for Magic Mushroom Licencing

Way2Grow Biopharma Company Announces Plans to Seek Health Canada Approval for Magic Mushroom Licencing
Share this article

 

OSOYOOS – Way2Grow Nurseries, a privately held biopharma company, announced today it is entering the productivity phase of cannabis cultivation, micropropagation, and extraction. The company further announced its preparation of a Health Canada application towards psychedelic research and development for a medicinal mushroom (Psilocybe semilanceata) Dealer Licence and for use of psilocybin production and extraction for planned preclinical research under scientific purposes.

Research plans include the investigation of cannabis and psilocybin mushroom’s growth plans and examination of their efficacy on treating unmet mental health conditions such as PTSD, addiction dependency, and anxiety.

The company has developed a new and strategic organic approach to the biopharmaceutical industry by combining its expertise in organic cultivation technology, an experienced genetic advancement team, innovative pharmaceutical research plans and IP development, coupled with the highest level of security. Way2Grow believes this unique combination will lead to the highest quality, safest organic biopharma and nutraceutical products.

Way2Grow is a privately-held biopharmaceutical company located in Osoyoos, British Columbia, and is regulated under the Cannabis Act and the Cannabis Regulations of Canada.

 

We seek safe harbor.

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.